Target72 kDa type IV collagenase(Homo sapiens (Human))
Preclinical Research Novartis Pharma
Curated by ChEMBL
Preclinical Research Novartis Pharma
Curated by ChEMBL
Affinity DataKi: 0.5nMAssay Description:Inhibitory potency against Matrix metalloprotease-2 (MMP-2)More data for this Ligand-Target Pair